Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
227 hedge funds and large institutions have $2.72B invested in Cantel Medical Corporation in 2016 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 80 increasing their positions, 79 reducing their positions, and 34 closing their positions.
14% more capital invested
Capital invested by funds: $2.38B → $2.72B (+$340M)
1% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 79
6% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 34
2% less funds holding
Funds holding: 231 → 227 (-4)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
34% less call options, than puts
Call options by funds: $897K | Put options by funds: $1.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$48.5M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$13.1M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$12.6M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.8M |
| 5 |
Neuberger Berman Group
New York
|
+$7.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Riverhead Capital Management
Wilmington,
Delaware
|
-$13.9M |
| 2 |
Morgan Stanley
New York
|
-$10.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.5M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$8.19M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$8.17M |
CMD Hedge Fund Activity: Q3 2016 in Review
227 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2016, worth a combined $2.72B — up 14% from $2.38B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of CMD and 32 opened new positions — a net loss of 2 holders — while 79 trimmed existing stakes and 80 added.
The largest buyer was Wells Fargo, adding an estimated $48.5M. The largest seller was Riverhead Capital Management, cutting an estimated $13.9M.
- 227 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2016, down from 231 in Q2 2016.
- Funds reported $2.72B of Cantel Medical Corporation stock for Q3 2016, up 14% quarter-over-quarter.
- 32 funds opened new Cantel Medical Corporation positions in Q3 2016 and 34 closed out, a net change of -2 holders.
- The largest Cantel Medical Corporation buyer in Q3 2016 was Wells Fargo, an estimated $48.5M added.
- The largest Cantel Medical Corporation seller in Q3 2016 was Riverhead Capital Management, an estimated $13.9M sold.
Based on aggregated 13F filings for Q3 2016.